IL1B and Huntington disease: Specifically, monitoring changes in pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-1β) and oxidative stress markers (e.g., SOD, GSH-PX, MDA) could offer valuable insights into HD’s anti-inflammatory and antioxidant properties.